SILINGARDI, Vittorio
 Distribuzione geografica
Continente #
NA - Nord America 7.955
EU - Europa 4.284
AS - Asia 3.887
SA - Sud America 511
AF - Africa 102
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 9
Totale 16.775
Nazione #
US - Stati Uniti d'America 7.785
IT - Italia 1.266
GB - Regno Unito 1.131
SG - Singapore 1.087
CN - Cina 1.083
SE - Svezia 452
HK - Hong Kong 414
BR - Brasile 370
VN - Vietnam 364
DE - Germania 273
FI - Finlandia 245
UA - Ucraina 232
TR - Turchia 219
FR - Francia 192
BD - Bangladesh 183
RU - Federazione Russa 183
IN - India 114
KR - Corea 109
BG - Bulgaria 73
CA - Canada 73
ID - Indonesia 53
AR - Argentina 44
NL - Olanda 42
MX - Messico 38
IQ - Iraq 31
MY - Malesia 31
ES - Italia 29
PK - Pakistan 28
ZA - Sudafrica 28
CO - Colombia 26
PL - Polonia 26
AU - Australia 24
JP - Giappone 24
EC - Ecuador 21
SA - Arabia Saudita 21
BZ - Belize 19
CL - Cile 18
IE - Irlanda 18
RO - Romania 18
CZ - Repubblica Ceca 17
BE - Belgio 16
AE - Emirati Arabi Uniti 15
IR - Iran 15
AT - Austria 13
KE - Kenya 13
NP - Nepal 13
PH - Filippine 13
CR - Costa Rica 12
MA - Marocco 12
VE - Venezuela 12
ET - Etiopia 11
LT - Lituania 10
EG - Egitto 9
TH - Thailandia 9
CH - Svizzera 8
DZ - Algeria 7
EU - Europa 7
TN - Tunisia 7
UZ - Uzbekistan 7
HU - Ungheria 6
JM - Giamaica 6
JO - Giordania 6
KZ - Kazakistan 6
PE - Perù 6
PY - Paraguay 6
TW - Taiwan 6
AZ - Azerbaigian 5
DK - Danimarca 5
GE - Georgia 5
HN - Honduras 5
IL - Israele 5
UY - Uruguay 5
DO - Repubblica Dominicana 4
EE - Estonia 4
MD - Moldavia 4
RS - Serbia 4
TT - Trinidad e Tobago 4
AL - Albania 3
AM - Armenia 3
BH - Bahrain 3
CM - Camerun 3
KG - Kirghizistan 3
MK - Macedonia 3
PR - Porto Rico 3
SC - Seychelles 3
AN - Antille olandesi 2
GT - Guatemala 2
LB - Libano 2
LK - Sri Lanka 2
NO - Norvegia 2
OM - Oman 2
PS - Palestinian Territory 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
BF - Burkina Faso 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
Totale 16.754
Città #
Santa Clara 849
Southend 778
Ashburn 714
Singapore 671
Fairfield 493
Chandler 455
Jacksonville 433
San Jose 414
Hong Kong 395
Hefei 380
Woodbridge 320
Dearborn 318
Council Bluffs 302
Houston 243
Wilmington 225
Nyköping 212
Ann Arbor 203
Beijing 201
Cambridge 192
Helsinki 164
Seattle 161
London 158
Los Angeles 150
Izmir 113
The Dalles 107
Ho Chi Minh City 106
Milan 103
Buffalo 95
New York 94
Princeton 86
Hanoi 82
Chicago 80
Seoul 80
San Diego 73
Eugene 71
Sofia 71
Rome 67
Des Moines 63
Columbus 59
Lauterbourg 57
Moscow 51
Jakarta 45
Dong Ket 44
Falls Church 39
Shanghai 34
São Paulo 32
Bremen 31
Orem 29
Dallas 28
Munich 26
Naples 26
Salt Lake City 26
Turin 24
Da Nang 22
Redwood City 21
Phoenix 20
Belize City 19
Chennai 19
Tokyo 19
Modena 18
Montreal 18
Toronto 18
Bari 17
Frankfurt am Main 17
Norwalk 17
Palermo 17
Brussels 16
Guangzhou 16
Baghdad 14
Mexico City 14
Verona 14
Warsaw 14
Bologna 13
Brno 13
Buraidah 13
Dublin 13
Falkenstein 13
Johannesburg 13
Saint Petersburg 13
San Mateo 13
Tampa 13
Turku 13
Florence 12
Nanjing 12
Ottawa 12
Saint Louis 12
Boardman 11
Brooklyn 11
Kunming 11
Philadelphia 11
Washington 11
Elk Grove Village 10
Haiphong 10
Madrid 10
Rio de Janeiro 10
Boston 9
Denver 9
Guayaquil 9
Kent 9
Livorno 9
Totale 10.921
Nome #
Sindrome mediastinica da mieloblastoma quale manifestazione d'esordio di leucemia mieloide acuta 783
The italian multi-center project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk 574
Il morbo di Hodgkin sclero-nodulare. Studio clinico-patologico 487
Experimental varicocele in the rat: early evaluation of the nitric oxide levels and histological alterations in the testicular tissue. 390
Italian family with two independent mutations:3358T/A in BRCA1 and 8756delA in BRCA2 genes. 350
Patogenesi complessa di una emopatia sistemica: la tricoleucemia 348
CCNU, vinblastine, procarbazine and prednisone (CVPP) with extended-field radiotherapy in the treatment of early unfavorable Hodgkin's disease - A prospective study on behalf of the Gruppo Italiano per lo Studio dei Linfomi (GISL) 321
Detection of circulating tumor cells by reverse transcriptase polymerase chain reaction of maspin in patients with breast cancer undergoing conventional-dose chemotherapy 319
PROMECE-CYTABOM VS MACOP-B IN ADVANCED AGGRESSIVE NON-HODGKINS-LYMPHOMA - LONG-TERM RESULTS OF A MULTICENTER STUDY OF THE ITALIAN LYMPHOMA STUDY-GROUP (GISL) 313
Effects of thymostimulin with combination chemotherapy in patients with aggressive non-Hodgkin's lymphoma. 311
A RANDOMIZED, DOUBLE-BLIND, CROSS-OVER STUDY COMPARING A LEVOSULPIRIDE-BASED AND A METOCLOPRAMIDE-BASED COMBINATION IN THE PREVENTION OF PROMECE-CYTABOM-INDUCED EMESIS 306
Transferability to clinical practice of the results of controlled clinical trials: The case of antiemetic prophylactic treatment for cancer chemotherapy-induced nausea and vomiting 303
Vinblastine, bleomycin, and methotrexate chemotherapy plus extended-field radiotherapy in early, favorably presenting, clinically staged Hodgkin's patients: The Gruppo Italiano per lo Studio dei Linfomi Experience 303
Identification of families with hereditary breast and ovarian cancer for clinical and mammographic surveillance: the Modena Study Group proposal 299
An oncologist-based model of cancer genetic counselling for hereditary breast and ovarian cancer 296
EPIDOXORUBICIN VS IDARUBICIN CONTAINING REGIMENS IN INTERMEDIATE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA - PRELIMINARY-RESULTS OF A MULTICENTRIC RANDOMIZED TRIAL 295
STIFF-MAN SYNDROME IN A PATIENT WITH HODGKINS-DISEASE - AN UNUSUAL PARANEOPLASTIC SYNDROME 290
A report of seven long survivors for evidence of prognostic factors in hairy cell leukemia 285
Different expressivity of BRCA1 and BRCA2: analysis of 179 Italian pedigrees with identified mutation 282
A pilot study on the use of the ProMACE CytaBOM regimen as a first-line treatment of advanced follicular non-Hodgkin's lymphoma 281
Retrospective analysis of mantle cell lymphoma: experience of the Gruppo Italiano per lo Studio dei Linfomi (GISL) 271
Hereditary risk of breast cancer: not only brca 254
Comment on "Cancer genetic counselling' by P.!Mandich et al. (Ann Oncol 2005; 16: 171) 252
Alimentazione e tumori II. Le vitamine 251
A multicenter randomized trial of two different ProMACE-CytaBOM derived protocols in aggressive non-Hodgkin's Lymphomas (NHL). A preliminary report 249
Bone marrow infiltration in Hairy cell leukemia after interferon therapy detected by magnetic resonance imagin 249
Complete remission in a case of aplastic anemia after treatment with antilymphocyte globulin 248
ANAPLASTIC LARGE-CELL LYMPHOMA (CD30+/KI-1+) - ANALYSIS OF 35 CASES FOLLOWED AT GISL CENTERS 246
Validation of the international prognostic index in working formulation group a low-grade non-Hodgkin's lymphoma: retrospective analysis of 137 patients from the Gruppo Italiano per lo studio dei linfomi registry. 246
Is an antiemetic prophylactic treatment needed for patients submitted to consecutive days of 5-fluorouracil? An observational study 243
HAIRY-CELL LEUKEMIA - A CLINICAL REVIEW BASED ON 725 CASES OF THE ITALIAN-COOPERATIVE-GROUP (ICGHCL) 243
Leucemia e tricoleucociti: studio clinico patologico di 30 casi 242
Hodgkin's disease prognosis: a directly predictive equation 240
Detection of bone marrow involvement in patients with cancer 238
Trapianto di midollo osseo nelle aplasie midollari. 238
Castleman's lymphoadenopathy: twenty years of observation. I. General considerations. Monodenopathic variety 235
Profilassi del vomito nei pazienti affetti da linfoma non-Hodgkin trattati con il protocollo ProMECE-CytaBOM. Risultati preliminari di uno studio clinico controllato 233
Prevention of cisplatin induced vomiting in patients with cancer. A pilot study with a multiagent protocol 229
Usefulness of breast MRI in a patient with genetic risk 229
Studio clinico immunologico di sei casi di morbo di Behcet 220
Castleman's lymphoadenopathy: twenty years of observation. II. Generalized form 219
Long-term results from MOPPEBVCAD chemotherapy with optional limited radiotherapy in advanced Hodgkin's disease 218
Screening clinico, mammografico e genetico del carcinoma mammario ereditario 215
Hodgkin's disease presenting below the diaphragm. The experience of the Gruppo Italiano Studio Linfomi (GISL) 214
MOPP/EBV/CAD hybrid chemotherapy with or without limited radiotherapy in advanced or unfavourably presenting Hodgkin's disease. A report from the Italian Lymphoma Study Group 208
Human lymphoblastoid interferon as initial therapy in hairy cell leukemia: a multicenter study in non-splenectomized patients 208
Alimentazione e tumori I. Considerazioni dietetiche generali: gli alimenti 207
Alimentazione e tumori III. Gli oligoelementi 203
Hairy cell leukemia: a reversible disease? A report of two cases of spontaneous remission 201
Utilità della Risonanza Magnetica Nucleare nello studio del midollo osseo di pazienti affetti da hairy Cell Leukemia 200
Istiocitosi maligna 200
Long term results of alpha interferon as initial therapy and splenectomy as consolidation therapy in patients with hairy cell leukemia. Final report from the Italian cooperative group for HCL 198
Relationship between prognostic factors and therapy in high grade non Hodgkin's lymphomas over two decades 196
The excretion of tryptophan metabolites in patients with different forms of haemoblastosis 191
Utilità diagnostica della risonanza magnetica nucleare in onco-ematologia 182
PROMACE-CYTABOM VERSUS MACOP-B IN INTERMEDIATE AND HIGH-GRADE NHL - PRELIMINARY-RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL 181
Gli interferoni in terapia antineoplastica 180
Ruolo attuale della chemioterapia nel carcinoma transizionale della vescica muscolo-invasivo 175
Cancer Incidence in the Province of Modena. Cancer Incidence in Five Continents Vol.VII 174
Free from failure survival in Hodgkin's disease. Long term analysis of 148 cases treated with a MOPP modified protocol 172
La chemioprevenzione del carcinoma mammario 170
REGIMEN-RELATED LIVER TOXICITY IN AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION 163
METHOTREXATE, VINBLASTINE, EPIDOXORUBICIN AND CISPLATIN (M-VEC) IN PATIENTS WITH LOCALLY ADVANCED TRANSITIONAL BLADDER-CANCER 160
La strategia terapeutica del GISL nei linfomi non-Hodgkin 157
La predisposizione genetica al cancro dell'ovaio. Individuazione e sorveglianza delle donne a rischio 145
Immunohistochemical labeling index in breast cancer after in vivo administration of bromodeoxiuridine 137
Emopoiesi extramidollare endotoracica in Morbo di Cooley dell'adulto 125
BrCa1 mutational analysis in a population of Italian women affected by hereditary breast or breast/ovarian cancer 13
Biological and clinical featuresof BRCA1and BRCA2 related tumors 13
Totale 17.017
Categoria #
all - tutte 56.881
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.881


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.294 28 159 111 129 40 105 72 64 149 73 223 141
2022/20231.403 123 130 109 125 180 238 18 131 173 24 58 94
2023/2024826 44 45 50 84 147 68 143 66 9 34 35 101
2024/20252.874 117 39 50 222 609 422 221 201 319 84 279 311
2025/20265.046 298 264 506 362 569 477 569 218 544 473 447 319
2026/2027214 214 0 0 0 0 0 0 0 0 0 0 0
Totale 17.017